Novo Nordisk's pricing strategies in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of cost gouging, stating the stark distinction involving U.S. costs and those in Europe and copyright.Even so, It can be crucial to remain aware that these discounts mightn't use universally, Particularly Using